Concordant phase 2 evidence and biological plausibility for rare tumours

The Lancet Oncology 2026

View at publisher

Authors: Olivia Le Saux

DOI: 10.1016/s1470-2045(26)00006-9

Cited by: 0

References: 8

Fields of Study & Subjects

Statistical Methods in Clinical Trials Sarcoma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

References 8